Compare Open Text Corporation (OTEX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Open Text Corporation vs State Street SPDR S&P Biotech ETF — how do they compare? Open Text Corporation trades at $23.7 (market cap $5.61B), while State Street SPDR S&P Biotech ETF trades at $153.7 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is the larger of the two by market cap, and Open Text Corporation pays a 4.82% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Open Text Corporation for 23 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| OTEX | XBI | |
|---|---|---|
Market Cap | $5.61B | $10.11B |
Volume | 1,197,475 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $39.69 | $169.55 |
52-Week Low | $20.01 | $104.99 |
Typical Hold Time | 23 Days | 38 Days |
Enterprise Value | $10.63B | — |
Dividend Yield | 4.82% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OpenText (OTEX) trades at $23.695, up 2.4% today, with a bearish technical signal despite recent earnings beats. The stock is valued at a P/E of 9.01 and P/S of 1.1, below sector averages, while showing strong profitability with a net margin of 12.26%. Recent news highlights a $1 billion senior secured notes offering and a partnership with Cohere to advance AI capabilities, indicating strategic debt management and growth initiatives.
The outlook is mixed: valuation discounts and cloud growth present opportunities, but high debt and bearish technicals pose risks. Analysts are cautiously optimistic with a $28.30 price target, though execution on AI integration and debt reduction will be critical for sustained upside.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Open Text Corporation
Open Text Corporation is a global leader in Enterprise Information Management (EIM) software and solutions. The company provides a comprehensive platform that helps organizations manage, secure, and leverage their unstructured digital content, including documents, emails, and media files. OTEX's offerings span content management, business process management, customer experience management, and security, serving large enterprises across various industries worldwide.
Read more on OTEX →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
